Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: Results of a 4-year follow-up study

Journal of the American Society of Nephrology

Volumn 16, Issue 5, 2005, Pages 1404-1412

  Perkins, Bruce A ^a,b   Nelson, Robert G ^c   Ostrander, Betsy E P ^a   Blouch, Kristina L ^d   Krolewski, Andrzej S ^a,b   Myers, Bryan D ^d   Warram, James H ^a  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; IOTALAMIC ACID; BIOLOGICAL MARKER; CREATININE; CYSTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MALE; PRIORITY JOURNAL; BLOOD; DIABETIC NEPHROPATHY; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; BIOLOGICAL MARKERS; CREATININE; CYSTATINS; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 23944450684     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004100854     Document Type: Article

References (34)

1. Hsu C-Y, Chertow GM, Curhan GC: Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int 61: 1567-1576, 2002
2. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
3. Price CP, Finney H. Developments in the assessment of glomerular filtration rate. Clin Chim Acta 297: 55-66, 2000
4. Massey D: Commentary: Clinical diagnostic use of cystatin C. J Clin Lab Anal 18: 55-60, 2004
5. Viberti G, Walker JD: Natural history and pathogenesis of diabetic nephropathy. J Diabet Complications 5: 72-75, 1991
6. Mogensen CE: How to protect the kidney in diabetic patients: With special reference to IDDM. Diabetes 46: S104-S111, 1997
7. Dworkin LD: Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 10: 551-553, 2001
8. Newman DJ: Cystatin C. Ann Clin Biochem 39: 89-104, 2002
9. Laterza OF, Price CP, Scott MG: Cystatin C: An improved estimator of glomerular filtration rate? Clin Chem 48: 699-707, 2002
10. Randers E, Erlandsen EJ: Serum cystatin C as an endogenous marker of the renal function-A review. Clin Chem Lab Med 37: 389-395, 1999
11. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J: Cystatin C-A new marker of glomerular filtration rate in children independent of age and height. Pediatrics 101: 875-881, 1998
12. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A: Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 59: 587-592, 1999
13. Mussap M, Ruzzante N, Varagnolo M, Plebani M: Quantitative automated particle-enhanced immunonephelometric assay for the routine measurement of human cystatin C. Clin Chem Lab Med 36: 859-865, 1998
14. Galteau MM, Guyon M, Gueguen R, Siest G: Determination of serum cystatin C: Biological variation and reference values. Clin Chem Lab Med 39: 850-857, 2001
15. Kazama JJ, Kutsuwada K, Ataka K, Maruyama H, Gejyo F: Serum cystatin C reliably detects renal dysfunction in patients with various renal diseases. Nephron 91: 13-20, 2002
16. Randers E, Erlandsen EJ, Pedersen OL, Hasling C, Danielsen H: Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function. Clin Nephrol 54: 203-209, 2000
17. Mussap M, Dalla Vestra M, Fioretto P, Sailer A, Varagnolo M, Nosadini R, Plebani M: Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 61: 1453-1461, 2002
18. Tan GD, Lewis AV, James TJ, Altmann P, Taylor RP, Levy JC: Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: Reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care 25: 2004-2009, 2002
19. Buysschaert M, Joudi I, Wallemacq P, Hermans MP: Comparative performance of serum cystatin-C versus serum creatinine in diabetic subjects. Diabetes Metab 29: 377-383, 2003
20. Hoek FJ, Kemperman FAW, Krediet RT: A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 18: 2024-2031, 2003
21. Xia LH, Bing XG, An XT: Serum cystatin C assay for the detection of early renal impairment in diabetic patients. J Clin Lab Anal 18: 31-35, 2004
22. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 335: 1636-1642, 1996
23. Myers BD, Nelson RG, Tan M, Beck GJ, Bennett PH, Knowler WC, Blouch K, Mitch WE: Progression of overt nephropathy in non-insulin-dependent diabetes. Kidney Int 47: 1781-1789, 1995
24. Myers BD, Nelson RG, Williams GW, Bennett PH, Hardy SA, Berg RL, Loon N, Knowler WC, Mitch WE: Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset. J Clin Invest 88: 524-530, 1991
25. Spinler SA, Nawarskas JJ, Boyce EG, Connors JE, Charland SL, Goldfarb S: Predictive performance of ten equations for estimating creatinine clearance in cardiac patients. lohexol Cooperative Study Group. Ann Pharmacother 32: 1275-1283, 1998
26. Dharnidharka VR, Kwon C, Stevens G: Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis. Am J Kidney Dis 40: 221-226, 2002
27. Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310, 1986
28. Apperloo AJ, de Zeeuw D, Donker AJ, de Jong PE: Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 1251-iothalamate and 131I-hippuran. J Am Soc Nephrol 7: 567-572, 1996
29. Gaspari F, Perico N, Remuzzi G: Application of newer clearance techniques for the determination of glomerular filtration rate. Curr Opin Nephrol Hypertens 7: 675-680, 1998
30. Lindeman RD, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33: 278-285, 1985
31. Rahn KH, Heidenreich S, Bruckner D: How to assess glomerular function and damage in humans. J Hypertens 17: 309-317, 1999
32. Nair KS, Pabico RC, Truglia JA, McKenna BA, Statt M, Lockwood DH: Mechanism of glomerular hyperfiltration after a protein meal in humans. Role of hormones and amino acids. Diabetes Care 17: 711-715, 1994
33. Wiseman MJ, Saunders AJ, Keen H, Viberti G: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 312: 617-621, 1985
34. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416-1421, 2004